| Lacosamide |
| (R)-2-Acetamido-N-benzyl-3-methoxypropanamide |
| (CAS 175481-36-4) |
 |
| Description： |
Lacosamide (Vimpat; Erlosamide) is a medication developed for the adjunctive treatment of partial-onset seizures and diabetic neuropathic pain.
IC50 value:
Target:
Lacosamide is a functionalized amino acid that produces activity in the maximal electroshock seizure (MES) test, that, like some other antiepileptic drugs (AEDs), are believed to act through voltage-gated sodium channels. Lacosamide enhances the slow inactivation of voltage-gated sodium channels without affecting the fast inactivation of voltage-gated sodium channels. This inactivation prevents the channel from opening, helping end the action potential. Many antiepileptic drugs, like carbamazepine or lamotrigine, slow the recovery from inactivation and hence reduce the ability of neurons to fire action potentials.
|
| Product No. |
KT20447 |
| Product Name |
Lacosamide |
| Synonyms |
Vimpat; Erlosamide |
| Formal Name |
(R)-2-Acetamido-N-benzyl-3-methoxypropanamide |
| CAS Number |
175481-36-4 |
| Molecular Formula |
C13H18N2O3 |
| Formula Weight |
250.29 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
5-FAM
5-Methoxypsoralen
5-TAMRA
6-FAM
6-FITC
A-769662
Acarbose
Adrafinil
Afobazole
|
|
